| pubmed-article:12576315 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C0016017 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C0376618 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C1120843 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C1155002 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C2259032 | lld:lifeskim |
| pubmed-article:12576315 | lifeskim:mentions | umls-concept:C1513344 | lld:lifeskim |
| pubmed-article:12576315 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:12576315 | pubmed:dateCreated | 2003-5-20 | lld:pubmed |
| pubmed-article:12576315 | pubmed:abstractText | P38 mitogen-activated protein kinase (MAPK) is an important component of intracellular signaling cascades that initiate various inflammatory cellular responses. To determine the role of p38 MAPK in the procoagulant response to lipopolysaccharide (LPS), 24 healthy subjects were exposed to an intravenous dose of LPS (4 ng/kg), preceded 3 hours earlier by orally administered 600 or 50 mg BIRB 796 BS (a specific p38 MAPK inhibitor), or placebo. The 600-mg dose of BIRB 796 BS strongly inhibited LPS-induced coagulation activation, as measured by plasma concentrations of the prothrombin fragment F1 + 2. BIRB 796 BS also dose dependently attenuated the activation and subsequent inhibition of the fibrinolytic system (plasma tissue-type plasminogen activator, plasmin-alpha2-antiplasmin complexes, and plasminogen activator inhibitor type 1) and endothelial cell activation (plasma soluble E-selectin and von Willebrand factor). Activation of p38 MAPK plays an important role in the procoagulant and endothelial cell response after in vivo exposure to LPS. | lld:pubmed |
| pubmed-article:12576315 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12576315 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12576315 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12576315 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12576315 | pubmed:issn | 0006-4971 | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:HackC ErikCE | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:BrangerJudith... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:Peppelenbosch... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:WeijerSebasti... | lld:pubmed |
| pubmed-article:12576315 | pubmed:author | pubmed-author:GuptaAbhyaA | lld:pubmed |
| pubmed-article:12576315 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12576315 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:12576315 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:12576315 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12576315 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12576315 | pubmed:pagination | 4446-8 | lld:pubmed |
| pubmed-article:12576315 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:meshHeading | pubmed-meshheading:12576315... | lld:pubmed |
| pubmed-article:12576315 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12576315 | pubmed:articleTitle | Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. | lld:pubmed |
| pubmed-article:12576315 | pubmed:affiliation | Department of Infectious Disease, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. j.branger@amc.uva.nl | lld:pubmed |
| pubmed-article:12576315 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12576315 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12576315 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12576315 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:5594 | entrezgene:pubmed | pubmed-article:12576315 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12576315 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12576315 | lld:pubmed |
